2024 Q2 Form 10-Q Financial Statement
#000149315224018344 Filed on May 09, 2024
Income Statement
Concept | 2024 Q2 | 2024 Q1 |
---|---|---|
Revenue | -$3.656M | -$3.223M |
YoY Change | -3.93% | -23.66% |
Cost Of Revenue | $1.214M | $1.214M |
YoY Change | 0.0% | 0.08% |
Gross Profit | -$186.9K | $313.8K |
YoY Change | -218.34% | 265.8% |
Gross Profit Margin | ||
Selling, General & Admin | $3.006M | $3.087M |
YoY Change | -8.55% | -19.14% |
% of Gross Profit | 983.71% | |
Research & Development | ||
YoY Change | ||
% of Gross Profit | ||
Depreciation & Amortization | ||
YoY Change | ||
% of Gross Profit | ||
Operating Expenses | $4.683M | $4.751M |
YoY Change | -9.55% | -13.94% |
Operating Profit | -$4.870M | -$4.437M |
YoY Change | -2.98% | -18.36% |
Interest Expense | -$6.996M | $1.214M |
YoY Change | -676.11% | 0.08% |
% of Operating Profit | ||
Other Income/Expense, Net | $462.8K | $449.6K |
YoY Change | -31.58% | -8.17% |
Pretax Income | -$10.65M | -$22.07M |
YoY Change | -31.81% | -577.97% |
Income Tax | $52.79K | $2.100K |
% Of Pretax Income | ||
Net Earnings | -$10.65M | -$22.07M |
YoY Change | -31.81% | -577.97% |
Net Earnings / Revenue | ||
Basic Earnings Per Share | -$0.45 | -$0.87 |
Diluted Earnings Per Share | -$0.45 | -$0.87 |
COMMON SHARES | ||
Basic Shares Outstanding | 23.35M shares | 25.35M shares |
Diluted Shares Outstanding | 23.41M shares | 25.39M shares |
Balance Sheet
Concept | 2024 Q2 | 2024 Q1 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | $54.38M | $50.81M |
YoY Change | 121.57% | 5.61% |
Cash & Equivalents | $54.38M | $50.81M |
Short-Term Investments | ||
Other Short-Term Assets | $282.6K | $467.2K |
YoY Change | -41.76% | -28.59% |
Inventory | ||
Prepaid Expenses | ||
Receivables | $83.84K | $137.7K |
Other Receivables | $71.05K | $236.3K |
Total Short-Term Assets | $54.82M | $51.66M |
YoY Change | 109.32% | 4.39% |
LONG-TERM ASSETS | ||
Property, Plant & Equipment | ||
YoY Change | ||
Goodwill | ||
YoY Change | ||
Intangibles | ||
YoY Change | ||
Long-Term Investments | $182.9M | $204.6M |
YoY Change | -22.56% | -15.11% |
Other Assets | $561.1K | $577.9K |
YoY Change | -4.97% | 7.19% |
Total Long-Term Assets | $183.5M | $205.2M |
YoY Change | -22.51% | -15.06% |
TOTAL ASSETS | ||
Total Short-Term Assets | $54.82M | $51.66M |
Total Long-Term Assets | $183.5M | $205.2M |
Total Assets | $238.3M | $256.9M |
YoY Change | -9.38% | -11.76% |
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | $2.003M | $1.271M |
YoY Change | -20.26% | -46.83% |
Accrued Expenses | ||
YoY Change | ||
Deferred Revenue | ||
YoY Change | ||
Short-Term Debt | $0.00 | $0.00 |
YoY Change | ||
Long-Term Debt Due | ||
YoY Change | ||
Total Short-Term Liabilities | $2.047M | $1.315M |
YoY Change | -24.16% | -48.98% |
LONG-TERM LIABILITIES | ||
Long-Term Debt | $73.92M | $73.83M |
YoY Change | 0.49% | 0.49% |
Other Long-Term Liabilities | ||
YoY Change | ||
Total Long-Term Liabilities | $73.92M | $73.83M |
YoY Change | 0.49% | 0.49% |
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | $2.047M | $1.315M |
Total Long-Term Liabilities | $73.92M | $73.83M |
Total Liabilities | $75.97M | $75.15M |
YoY Change | -0.38% | -1.19% |
SHAREHOLDERS EQUITY | ||
Retained Earnings | ||
YoY Change | ||
Common Stock | $233.8K | $253.5K |
YoY Change | -7.96% | -10.53% |
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | ||
YoY Change | ||
Treasury Stock Shares | ||
Shareholders Equity | $162.3M | $181.7M |
YoY Change | ||
Total Liabilities & Shareholders Equity | $238.3M | $256.9M |
YoY Change | -9.38% | -11.76% |
Cashflow Statement
Concept | 2024 Q2 | 2024 Q1 |
---|---|---|
OPERATING ACTIVITIES | ||
Net Income | -$10.65M | -$22.07M |
YoY Change | -31.81% | -577.97% |
Depreciation, Depletion And Amortization | ||
YoY Change | ||
Cash From Operating Activities | $12.97M | $22.74M |
YoY Change | -228.74% | 180.65% |
INVESTING ACTIVITIES | ||
Capital Expenditures | ||
YoY Change | ||
Acquisitions | ||
YoY Change | ||
Other Investing Activities | ||
YoY Change | ||
Cash From Investing Activities | ||
YoY Change | ||
FINANCING ACTIVITIES | ||
Cash Dividend Paid | $107.8K | |
YoY Change | 0.0% | |
Common Stock Issuance & Retirement, Net | ||
YoY Change | ||
Debt Paid & Issued, Net | ||
YoY Change | ||
Cash From Financing Activities | -9.400M | -$107.8K |
YoY Change | -30.37% | 0.0% |
NET CHANGE | ||
Cash From Operating Activities | 12.97M | $22.74M |
Cash From Investing Activities | ||
Cash From Financing Activities | -9.400M | -$107.8K |
Net Change In Cash | 3.565M | $22.64M |
YoY Change | -115.13% | 183.09% |
FREE CASH FLOW | ||
Cash From Operating Activities | $12.97M | $22.74M |
Capital Expenditures | ||
Free Cash Flow | ||
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2024Q1 | us-gaap |
Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
|
467149 | usd |
CY2024Q1 | SSSS |
Increase Decrease In Escrow Proceeds Receivable
IncreaseDecreaseInEscrowProceedsReceivable
|
-72990 | usd |
CY2024Q1 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2024 | |
CY2024Q1 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001509470 | |
CY2023 | us-gaap |
Debt Instrument Maturity Date
DebtInstrumentMaturityDate
|
2026-12-30 | |
CY2024Q1 | SSSS |
Purchases Of Us Treasury Bills Investments
PurchasesOfUSTreasuryBillsInvestments
|
usd | |
CY2023 | us-gaap |
Debt Instrument Maturity Date
DebtInstrumentMaturityDate
|
2026-12-30 | |
CY2024Q1 | dei |
Document Type
DocumentType
|
10-Q | |
CY2024Q1 | dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | |
CY2024Q1 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2024-03-31 | |
CY2024Q1 | SSSS |
Investments In U.S.Treasury Bills Cost
InvestmentsInU.s.TreasuryBillsCost
|
29621913 | usd |
CY2023Q4 | SSSS |
Investments In U.S.Treasury Bills Cost
InvestmentsInU.s.TreasuryBillsCost
|
63810855 | usd |
CY2024Q1 | SSSS |
Escrow Proceeds Receivable
EscrowProceedsReceivable
|
236303 | usd |
CY2024Q1 | SSSS |
Interest And Dividends Receivable
InterestAndDividendsReceivable
|
137657 | usd |
CY2024Q1 | us-gaap |
Deferred Costs Current And Noncurrent
DeferredCostsCurrentAndNoncurrent
|
577900 | usd |
CY2024Q1 | us-gaap |
Assets
Assets
|
256870892 | usd |
CY2024Q1 | us-gaap |
Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
|
1270583 | usd |
CY2024Q1 | us-gaap |
Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
|
44700 | usd |
CY2024Q1 | us-gaap |
Notes Payable
NotesPayable
|
73834474 | usd |
CY2024Q1 | us-gaap |
Liabilities
Liabilities
|
75149757 | usd |
CY2024Q1 | us-gaap |
Assets Net
AssetsNet
|
181721135 | usd |
CY2024Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
CY2023Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
CY2024Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | shares |
CY2023Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | shares |
CY2024Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
25353284 | shares |
CY2024Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
25353284 | shares |
CY2023Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
25445805 | shares |
CY2023Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
25445805 | shares |
CY2024Q1 | us-gaap |
Common Stock Value
CommonStockValue
|
253533 | usd |
CY2024Q1 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
248883867 | usd |
CY2024Q1 | SSSS |
Accumulated Net Investment Loss
AccumulatedNetInvestmentLoss
|
-7527013 | usd |
CY2024Q1 | SSSS |
Accumulated Net Realized Gain On Investments Net Of Distributions
AccumulatedNetRealizedGainOnInvestmentsNetOfDistributions
|
-12772846 | usd |
CY2024Q1 | SSSS |
Accumulated Net Unrealized Depreciation Appreciation Of Investments
AccumulatedNetUnrealizedDepreciationAppreciationOfInvestments
|
-47116406 | usd |
CY2024Q1 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
181721135 | usd |
CY2024Q1 | us-gaap |
Net Asset Value Per Share
NetAssetValuePerShare
|
7.17 | |
CY2024Q1 | us-gaap |
Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
|
0.0600 | pure |
CY2024Q1 | us-gaap |
Debt Instrument Maturity Date
DebtInstrumentMaturityDate
|
2026-12-30 | |
CY2024Q1 | us-gaap |
Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
|
0.0600 | pure |
CY2024Q1 | us-gaap |
Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
|
0.0653 | pure |
CY2024Q1 | us-gaap |
Debt Instrument Face Amount
DebtInstrumentFaceAmount
|
75000000 | usd |
CY2023Q4 | us-gaap |
Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
|
0.0653 | pure |
CY2023Q4 | us-gaap |
Debt Instrument Face Amount
DebtInstrumentFaceAmount
|
75000000 | usd |
CY2024Q1 | us-gaap |
Investment Income Net
InvestmentIncomeNet
|
1528091 | usd |
CY2023Q1 | us-gaap |
Investment Income Net
InvestmentIncomeNet
|
1299082 | usd |
CY2024Q1 | us-gaap |
Compensation Expense Excluding Cost Of Good And Service Sold
CompensationExpenseExcludingCostOfGoodAndServiceSold
|
2185318 | usd |
CY2023Q1 | us-gaap |
Compensation Expense Excluding Cost Of Good And Service Sold
CompensationExpenseExcludingCostOfGoodAndServiceSold
|
2136754 | usd |
CY2024Q1 | SSSS |
Directors Fees
DirectorsFees
|
171113 | usd |
CY2023Q1 | SSSS |
Directors Fees
DirectorsFees
|
160565 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
4616509 | usd |
CY2024Q1 | SSSS |
Realized Investment Gain Losses
RealizedInvestmentGainLosses
|
-424074 | usd |
CY2023Q1 | SSSS |
Realized Investment Gain Losses
RealizedInvestmentGainLosses
|
189343 | usd |
CY2024Q1 | us-gaap |
Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
|
-18418370 | usd |
CY2023Q1 | us-gaap |
Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
|
8648931 | usd |
CY2024Q1 | us-gaap |
Professional Fees
ProfessionalFees
|
728559 | usd |
CY2023Q1 | us-gaap |
Professional Fees
ProfessionalFees
|
990834 | usd |
CY2024Q1 | us-gaap |
Interest Expense
InterestExpense
|
1214267 | usd |
CY2023Q1 | us-gaap |
Interest Expense
InterestExpense
|
1213286 | usd |
CY2024Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
2100 | usd |
CY2023Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
529780 | usd |
CY2024Q1 | us-gaap |
Other Expenses
OtherExpenses
|
449636 | usd |
CY2023Q1 | us-gaap |
Other Expenses
OtherExpenses
|
489628 | usd |
CY2024Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
4750993 | usd |
CY2023Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
5520847 | usd |
CY2024Q1 | us-gaap |
Net Investment Income
NetInvestmentIncome
|
-3222902 | usd |
CY2023Q1 | us-gaap |
Net Investment Income
NetInvestmentIncome
|
-4221765 | usd |
CY2024Q1 | us-gaap |
Realized Investment Gains Losses
RealizedInvestmentGainsLosses
|
-424074 | usd |
CY2023Q1 | us-gaap |
Realized Investment Gains Losses
RealizedInvestmentGainsLosses
|
189343 | usd |
CY2024Q1 | us-gaap |
Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
|
-18418370 | usd |
CY2023Q1 | us-gaap |
Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
|
8648931 | usd |
CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-22065346 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
4616509 | usd |
CY2024Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.87 | |
CY2023Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.16 | |
CY2024Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.87 | |
CY2023Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.16 | |
CY2024Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
25393490 | shares |
CY2023Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
28378529 | shares |
CY2024Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
25393490 | shares |
CY2023Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
28378529 | shares |
CY2023Q4 | us-gaap |
Assets Net
AssetsNet
|
203357646 | usd |
CY2022Q4 | us-gaap |
Assets Net
AssetsNet
|
210020702 | usd |
CY2024Q1 | us-gaap |
Net Investment Income
NetInvestmentIncome
|
-3222902 | usd |
CY2023Q1 | us-gaap |
Net Investment Income
NetInvestmentIncome
|
-4221765 | usd |
CY2024Q1 | us-gaap |
Realized Investment Gains Losses
RealizedInvestmentGainsLosses
|
-424074 | usd |
CY2023Q1 | us-gaap |
Realized Investment Gains Losses
RealizedInvestmentGainsLosses
|
189343 | usd |
CY2024Q1 | us-gaap |
Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
|
-18418370 | usd |
CY2023Q1 | us-gaap |
Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
|
8648931 | usd |
CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-22065346 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
4616509 | usd |
CY2024Q1 | SSSS |
Stock Issued During Period Values Share Based Compensation Gross
StockIssuedDuringPeriodValuesShareBasedCompensationGross
|
428835 | usd |
CY2023Q1 | SSSS |
Stock Issued During Period Values Share Based Compensation Gross
StockIssuedDuringPeriodValuesShareBasedCompensationGross
|
405858 | usd |
CY2024Q1 | SSSS |
Investment Company Capital Share Transactions
InvestmentCompanyCapitalShareTransactions
|
428835 | usd |
CY2023Q1 | SSSS |
Investment Company Capital Share Transactions
InvestmentCompanyCapitalShareTransactions
|
405858 | usd |
CY2024Q1 | us-gaap |
Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
|
-21636511 | usd |
CY2023Q1 | us-gaap |
Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
|
5022367 | usd |
CY2024Q1 | us-gaap |
Assets Net
AssetsNet
|
181721135 | usd |
CY2023Q1 | us-gaap |
Assets Net
AssetsNet
|
215043069 | usd |
CY2023Q4 | us-gaap |
Shares Outstanding
SharesOutstanding
|
25445805 | shares |
CY2022Q4 | us-gaap |
Shares Outstanding
SharesOutstanding
|
28429499 | shares |
CY2024Q1 | us-gaap |
Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
|
92521 | shares |
CY2023Q1 | us-gaap |
Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
|
90919 | shares |
CY2024Q1 | us-gaap |
Shares Outstanding
SharesOutstanding
|
25353284 | shares |
CY2023Q1 | us-gaap |
Shares Outstanding
SharesOutstanding
|
28338580 | shares |
CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-22065346 | usd |
CY2024Q1 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
106093 | usd |
CY2023Q1 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
104936 | usd |
CY2024Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
428835 | usd |
CY2023Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
405858 | usd |
CY2024Q1 | SSSS |
Adjustments To Escrow Proceeds Receivable
AdjustmentsToEscrowProceedsReceivable
|
-72997 | usd |
CY2023Q1 | SSSS |
Adjustments To Escrow Proceeds Receivable
AdjustmentsToEscrowProceedsReceivable
|
108394 | usd |
CY2024Q1 | SSSS |
Accrued Interest On Us Treasury Bills
AccruedInterestOnUSTreasuryBills
|
376834 | usd |
CY2023Q1 | SSSS |
Accrued Interest On Us Treasury Bills
AccruedInterestOnUSTreasuryBills
|
458580 | usd |
CY2024Q1 | SSSS |
Purchases Of Portfolio Investments
PurchasesOfPortfolioInvestments
|
10003934 | usd |
CY2023Q1 | SSSS |
Purchases Of Portfolio Investments
PurchasesOfPortfolioInvestments
|
2003698 | usd |
CY2023Q1 | SSSS |
Purchases Of Us Treasury Bills Investments
PurchasesOfUSTreasuryBillsInvestments
|
35497676 | usd |
CY2024Q1 | SSSS |
Proceeds From Sales Or Maturity Of Investments Portfolio Investments
ProceedsFromSalesOrMaturityOfInvestmentsPortfolioInvestments
|
318316 | usd |
CY2023Q1 | SSSS |
Proceeds From Sales Or Maturity Of Investments Portfolio Investments
ProceedsFromSalesOrMaturityOfInvestmentsPortfolioInvestments
|
2860159 | usd |
CY2024Q1 | SSSS |
Proceeds From Sales Or Maturity Of Investments Us Treasury Bills
ProceedsFromSalesOrMaturityOfInvestmentsUSTreasuryBills
|
34547625 | usd |
CY2023Q1 | SSSS |
Proceeds From Sales Or Maturity Of Investments Us Treasury Bills
ProceedsFromSalesOrMaturityOfInvestmentsUSTreasuryBills
|
45000118 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-27453 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-72804 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Interest And Dividends Receivable
IncreaseDecreaseInInterestAndDividendsReceivable
|
5050 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Interest And Dividends Receivable
IncreaseDecreaseInInterestAndDividendsReceivable
|
-33758 | usd |
CY2023Q1 | SSSS |
Increase Decrease In Escrow Proceeds Receivable
IncreaseDecreaseInEscrowProceedsReceivable
|
-18647 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
924275 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
1680946 | usd |
CY2024Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
22743870 | usd |
CY2023Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
8103901 | usd |
CY2024Q1 | us-gaap |
Payments Of Dividends
PaymentsOfDividends
|
107823 | usd |
CY2023Q1 | us-gaap |
Payments Of Dividends
PaymentsOfDividends
|
107823 | usd |
CY2024Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-107823 | usd |
CY2023Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-107823 | usd |
CY2024Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
22636047 | usd |
CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
7996078 | usd |
CY2023Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
28178352 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
40117598 | usd |
CY2024Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
50814399 | usd |
CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
48113676 | usd |
CY2024Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
1125000 | usd |
CY2023Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
1125000 | usd |
CY2024Q1 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
2100 | usd |
CY2023Q1 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
4314 | usd |
CY2024Q1 | us-gaap |
Nature Of Operations
NatureOfOperations
|
<p id="xdx_80B_eus-gaap--NatureOfOperations_z7KkadUHRed8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1—<span id="xdx_82A_zjoMCdLFCHA2">NATURE OF OPERATIONS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SuRo Capital Corp. (“we”, “us”, “our”, the “Company” or “SuRo Capital”), formerly known as Sutter Rock Capital Corp. and as GSV Capital Corp. and formed in September 2010 as a Maryland corporation, is an internally managed, non-diversified closed-end management investment company. The Company has elected to be regulated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “1940 Act”), and has elected to be treated, and intends to qualify annually, as a regulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s date of inception was January 6, 2011, which is the date it commenced development stage activities. The Company’s common stock is currently listed on the Nasdaq Global Select Market under the symbol “SSSS” (formerly “GSVC”). Prior to November 24, 2021, the Company’s common stock traded on the Nasdaq Capital Market under the same symbol (“SSSS”). The Company began its investment operations during the second quarter of 2011.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The table below displays the Company’s subsidiaries as of March 31, 2024, which, other than GSV Capital Lending, LLC (“GCL”) and SuRo Capital Sports, LLC, are collectively referred to as the “Taxable Subsidiaries.” The Taxable Subsidiaries were formed to hold certain portfolio investments. The Taxable Subsidiaries, including their associated portfolio investments, are consolidated with the Company for accounting purposes, but have elected to be treated as separate entities for U.S. federal income tax purposes. GCL was formed to originate portfolio loan investments within the state of California and is consolidated with the Company for accounting purposes. Refer to “Note 2—Significant Accounting Policies—<i>Basis of Consolidation</i>” below for further detail.</span></p> <p id="xdx_896_ecustom--ScheduleOfSubsidiariesOfCompanyTableTextBlock_zKrlc3YJyeW5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BC_zl9IuryViyE4" style="display: none">SCHEDULE OF COMPANY’S SUBSIDIARIES</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Subsidiary</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Jurisdiction of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Incorporation</b></span></p></td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Formation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Date</b></span></p></td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Owned</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 48%">GCL</td><td style="width: 2%"> </td> <td style="width: 16%; text-align: center"><span id="xdx_906_edei--EntityIncorporationStateCountryCode_c20240101__20240331__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GCLMember_z6V3tZtpX6T2" title="Jurisdiction of Incorporation">Delaware</span></td><td style="width: 2%"> </td> <td id="xdx_985_edei--EntityIncorporationDateOfIncorporation_c20240101__20240331__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GCLMember_zwBGSv7wnLHa" style="width: 16%; text-align: center" title="Formation Date">April 13, 2012</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_988_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_c20240331__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GCLMember_zHulq8lcFoOk" style="width: 12%; text-align: right" title="Percentage Owned">100</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">SuRo Capital Sports, LLC (“SuRo Sports”)</td><td> </td> <td style="text-align: center"><span id="xdx_906_edei--EntityIncorporationStateCountryCode_c20240101__20240331__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SuRoCapitalSportsLLCSuRoSportsMember_zFHwXWnsMjhk" title="Jurisdiction of Incorporation">Delaware</span></td><td> </td> <td id="xdx_982_edei--EntityIncorporationDateOfIncorporation_c20240101__20240331__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SuRoCapitalSportsLLCSuRoSportsMember_zrqvBID0Oapk" style="text-align: center" title="Formation Date">March 19, 2021</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_c20240331__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SuRoCapitalSportsLLCSuRoSportsMember_zb88gpTjSobj" style="text-align: right" title="Percentage Owned">100</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Subsidiaries below are referred to collectively as the “Taxable Subsidiaries”</td><td> </td> <td> </td><td> </td> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">GSVC AE Holdings, Inc. (“GAE”)</td><td> </td> <td style="text-align: center"><span id="xdx_900_edei--EntityIncorporationStateCountryCode_c20240101__20240331__srt--ConsolidatedEntitiesAxis__custom--TaxableSubsidiariesMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GSVCAEHoldingsIncGAEMember_zPs5PSCiN8sl" title="Jurisdiction of Incorporation">Delaware</span></td><td> </td> <td id="xdx_985_edei--EntityIncorporationDateOfIncorporation_c20240101__20240331__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GSVCAEHoldingsIncGAEMember__srt--ConsolidatedEntitiesAxis__custom--TaxableSubsidiariesMember_z4lbm9qIOa91" style="text-align: center" title="Formation Date">November 28, 2012</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_c20240331__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GSVCAEHoldingsIncGAEMember__srt--ConsolidatedEntitiesAxis__custom--TaxableSubsidiariesMember_zSETRowekpHg" style="text-align: right" title="Percentage Owned">100</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">GSVC AV Holdings, Inc. (“GAV”)</td><td> </td> <td style="text-align: center"><span id="xdx_906_edei--EntityIncorporationStateCountryCode_c20240101__20240331__srt--ConsolidatedEntitiesAxis__custom--TaxableSubsidiariesMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GSVCAVHoldingsIncGAVMember_zVfJmiAyhtj9" title="Jurisdiction of Incorporation">Delaware</span></td><td> </td> <td id="xdx_98A_edei--EntityIncorporationDateOfIncorporation_c20240101__20240331__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GSVCAVHoldingsIncGAVMember__srt--ConsolidatedEntitiesAxis__custom--TaxableSubsidiariesMember_zDJTK6hoJ6Oi" style="text-align: center" title="Formation Date">November 28, 2012</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_c20240331__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GSVCAVHoldingsIncGAVMember__srt--ConsolidatedEntitiesAxis__custom--TaxableSubsidiariesMember_zKSwLBDqxoGh" style="text-align: right" title="Percentage Owned">100</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">GSVC SW Holdings, Inc. (“GSW”)</td><td> </td> <td style="text-align: center"><span id="xdx_90B_edei--EntityIncorporationStateCountryCode_c20240101__20240331__srt--ConsolidatedEntitiesAxis__custom--TaxableSubsidiariesMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GSVCSWHoldingsIncGSWMember_zJZugGOs44hi" title="Jurisdiction of Incorporation">Delaware</span></td><td> </td> <td id="xdx_983_edei--EntityIncorporationDateOfIncorporation_c20240101__20240331__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GSVCSWHoldingsIncGSWMember__srt--ConsolidatedEntitiesAxis__custom--TaxableSubsidiariesMember_zfzxJTcTd7Rf" style="text-align: center" title="Formation Date">November 28, 2012</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20240331__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GSVCSWHoldingsIncGSWMember__srt--ConsolidatedEntitiesAxis__custom--TaxableSubsidiariesMember_zRxel5wuGpQi" style="text-align: right" title="Percentage Owned">100</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">GSVC SVDS Holdings, Inc. (“SVDS”)</td><td> </td> <td style="text-align: center"><span id="xdx_90E_edei--EntityIncorporationStateCountryCode_c20240101__20240331__srt--ConsolidatedEntitiesAxis__custom--TaxableSubsidiariesMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GSVCSVDSHoldingsIncSVDSMember_zkcI5zJn6KH4" title="Jurisdiction of Incorporation">Delaware</span></td><td> </td> <td id="xdx_98C_edei--EntityIncorporationDateOfIncorporation_c20240101__20240331__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GSVCSVDSHoldingsIncSVDSMember__srt--ConsolidatedEntitiesAxis__custom--TaxableSubsidiariesMember_z1thruqu2o7j" style="text-align: center" title="Formation Date">August 13, 2013</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20240331__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GSVCSVDSHoldingsIncSVDSMember__srt--ConsolidatedEntitiesAxis__custom--TaxableSubsidiariesMember_zewylIcgG2Mj" style="text-align: right" title="Percentage Owned">100</td><td style="text-align: left">%</td></tr> </table> <p id="xdx_8A7_zeBQDWwMCCh6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s investment objective is to maximize its portfolio’s total return, principally by seeking capital gains on its equity and equity-related investments, and to a lesser extent, income from debt investments. The Company invests principally in the equity securities of what it believes to be rapidly growing venture capital-backed emerging companies. The Company may invest in these portfolio companies through offerings of the prospective portfolio companies, transactions on secondary marketplaces for private companies, or negotiations with selling stockholders. In addition, the Company may invest in private credit and in founders equity, founders warrants, forward purchase agreements, and private investment in public equity transactions of special purpose acquisition companies (“SPACs”). The Company may also invest on an opportunistic basis in select publicly traded equity securities or certain non-U.S. companies that otherwise meet its investment criteria, subject to any applicable limitations under the 1940 Act.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SURO CAPITAL CORP. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS March 31, 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> | |
CY2024Q1 | us-gaap |
Deferred Finance Costs Gross
DeferredFinanceCostsGross
|
1165526 | usd |
CY2023Q4 | us-gaap |
Deferred Finance Costs Gross
DeferredFinanceCostsGross
|
1254793 | usd |
CY2024Q1 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p id="xdx_84F_eus-gaap--UseOfEstimates_z4qOv6yrbxZ" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_863_z2B4Rd1btCyk">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of Condensed Consolidated Financial Statements in accordance with GAAP requires the Company’s management to make a number of significant estimates. These include estimates of the fair value of certain assets and liabilities and other estimates that affect the reported amounts of certain assets and liabilities as of the date of the Condensed Consolidated Financial Statements and the reported amounts of certain revenues and expenses during the reporting period. It is likely that changes in these estimates may occur in the near term. The Company’s estimates are inherently subjective in nature and actual results could differ materially from such estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> | |
CY2024Q1 | SSSS |
Escrow Proceeds Receivable
EscrowProceedsReceivable
|
236303 | usd |
CY2023Q4 | SSSS |
Escrow Proceeds Receivable
EscrowProceedsReceivable
|
309293 | usd |
CY2023Q4 | us-gaap |
Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
|
0.0600 | pure |
CY2024Q1 | SSSS |
Description For Deferred Financing Costs
DescriptionForDeferredFinancingCosts
|
The Company records fees and expenses incurred in connection with its 6.00% Notes due 2026 as deferred debt issuance costs. Such costs are reflected in the carrying value of the 6.00% Notes due 2026, and not the Company’s deferred financing costs | |
CY2024Q1 | us-gaap |
Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
|
577900 | usd |
CY2023Q4 | us-gaap |
Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
|
594726 | usd |
CY2024Q1 | us-gaap |
Deferred Costs Current And Noncurrent
DeferredCostsCurrentAndNoncurrent
|
577900 | usd |
CY2023Q4 | us-gaap |
Deferred Costs Current And Noncurrent
DeferredCostsCurrentAndNoncurrent
|
594726 | usd |
CY2024Q1 | us-gaap |
Deferred Finance Costs Net
DeferredFinanceCostsNet
|
1743426 | usd |
CY2023Q4 | us-gaap |
Deferred Finance Costs Net
DeferredFinanceCostsNet
|
1849519 | usd |
CY2019Q2 | us-gaap |
Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
|
P5Y | |
CY2024Q1 | us-gaap |
Escrow Deposit
EscrowDeposit
|
0 | usd |
CY2023Q4 | us-gaap |
Escrow Deposit
EscrowDeposit
|
0 | usd |
CY2023Q4 | us-gaap |
Assets Fair Value Disclosure
AssetsFairValueDisclosure
|
168568251 | usd |
CY2023Q4 | us-gaap |
Assets Fair Value Disclosure
AssetsFairValueDisclosure
|
168568251 | usd |
CY2023 | SSSS |
Fair Value Asset Recurring Basis Still Held Unrealized Gain And Loss Oci
FairValueAssetRecurringBasisStillHeldUnrealizedGainAndLossOci
|
3136307 | usd |
CY2024Q1 | SSSS |
Number Of Positions
NumberOfPositions
|
63 | |
CY2024Q1 | SSSS |
Number Of Portfolio Companies
NumberOfPortfolioCompanies
|
38 | |
CY2023Q4 | SSSS |
Number Of Positions
NumberOfPositions
|
63 | |
CY2023Q4 | SSSS |
Number Of Portfolio Companies
NumberOfPortfolioCompanies
|
38 | |
CY2024Q1 | us-gaap |
Investment Owned At Fair Value
InvestmentOwnedAtFairValue
|
175015571 | usd |
CY2024Q1 | SSSS |
Investment Owned Percent Of Investment Portfolio
InvestmentOwnedPercentOfInvestmentPortfolio
|
1.000 | pure |
CY2024Q1 | us-gaap |
Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
|
0.963 | pure |
CY2023Q4 | us-gaap |
Investment Owned At Fair Value
InvestmentOwnedAtFairValue
|
184081249 | usd |
CY2023Q4 | SSSS |
Investment Owned Percent Of Investment Portfolio
InvestmentOwnedPercentOfInvestmentPortfolio
|
1.000 | pure |
CY2023Q4 | us-gaap |
Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
|
0.906 | pure |
CY2024Q1 | us-gaap |
Investment Owned At Fair Value
InvestmentOwnedAtFairValue
|
175015571 | usd |
CY2024Q1 | SSSS |
Investment Owned Percent Of Investment Portfolio
InvestmentOwnedPercentOfInvestmentPortfolio
|
1.000 | pure |
CY2024Q1 | us-gaap |
Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
|
0.963 | pure |
CY2023Q4 | us-gaap |
Investment Owned At Fair Value
InvestmentOwnedAtFairValue
|
184081249 | usd |
CY2023Q4 | SSSS |
Investment Owned Percent Of Investment Portfolio
InvestmentOwnedPercentOfInvestmentPortfolio
|
1.000 | pure |
CY2023Q4 | us-gaap |
Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
|
0.906 | pure |
CY2024Q1 | us-gaap |
Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
|
204637484 | usd |
CY2023Q4 | us-gaap |
Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
|
247892104 | usd |
CY2023Q4 | us-gaap |
Assets Fair Value Disclosure
AssetsFairValueDisclosure
|
168568251 | usd |
CY2024Q1 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
|
10003934 | usd |
CY2024Q1 | SSSS |
Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain And Loss
FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainAndLoss
|
-16738799 | usd |
CY2024Q1 | us-gaap |
Assets Fair Value Disclosure
AssetsFairValueDisclosure
|
161833386 | usd |
CY2024Q1 | SSSS |
Fair Value Asset Recurring Basis Still Held Unrealized Gain And Loss Oci
FairValueAssetRecurringBasisStillHeldUnrealizedGainAndLossOci
|
-16738799 | usd |
CY2022Q4 | us-gaap |
Assets Fair Value Disclosure
AssetsFairValueDisclosure
|
143865093 | usd |
CY2022Q4 | us-gaap |
Assets Fair Value Disclosure
AssetsFairValueDisclosure
|
143865093 | usd |
CY2023 | SSSS |
Transfers
Transfers
|
-2711842 | usd |
CY2023 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
|
24485430 | usd |
CY2023 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
|
-1374302 | usd |
CY2023 | SSSS |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Exercises And Conversions
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisExercisesAndConversions
|
30820 | usd |
CY2023 | us-gaap |
Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
|
-9815023 | usd |
CY2023 | SSSS |
Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain And Loss
FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainAndLoss
|
14088075 | usd |
CY2023Q3 | srt |
Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
|
60000000.0 | usd |
CY2023Q1 | us-gaap |
Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
|
0 | shares |
CY2024Q1 | us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
-22065346 | usd |
CY2023Q1 | us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
4616509 | usd |
CY2024Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
25393490 | shares |
CY2023Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
28378529 | shares |
CY2024Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.87 | |
CY2023Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.16 | |
CY2024Q1 | SSSS |
Income Loss From Continuing Operations Diluted
IncomeLossFromContinuingOperationsDiluted
|
-22065346 | usd |
CY2023Q1 | SSSS |
Income Loss From Continuing Operations Diluted
IncomeLossFromContinuingOperationsDiluted
|
4616509 | usd |
CY2024Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
25393490 | shares |
CY2023Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
28378529 | shares |
CY2024Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.87 | |
CY2023Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.16 | |
CY2024Q1 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
64449 | usd |
CY2023Q4 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
112485 | usd |
CY2024Q1 | us-gaap |
Security Deposit
SecurityDeposit
|
16574 | usd |
CY2023Q4 | us-gaap |
Security Deposit
SecurityDeposit
|
16574 | usd |
CY2024Q1 | us-gaap |
Operating Lease Expense
OperatingLeaseExpense
|
52662 | usd |
CY2023Q1 | us-gaap |
Operating Lease Expense
OperatingLeaseExpense
|
48723 | usd |
CY2024Q1 | us-gaap |
Lessee Operating Lease Remaining Lease Term
LesseeOperatingLeaseRemainingLeaseTerm
|
P0Y3M18D | |
CY2024Q1 | us-gaap |
Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
|
0.0300 | pure |
CY2024Q1 | us-gaap |
Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
|
65330 | usd |
CY2024Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
65330 | usd |
CY2023Q4 | us-gaap |
Net Asset Value Per Share
NetAssetValuePerShare
|
7.99 | |
CY2022Q4 | us-gaap |
Net Asset Value Per Share
NetAssetValuePerShare
|
7.39 | |
CY2024Q1 | us-gaap |
Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
|
-0.13 | |
CY2023Q1 | us-gaap |
Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
|
-0.15 | |
CY2024Q1 | us-gaap |
Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
|
-0.02 | |
CY2023Q1 | us-gaap |
Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
|
0.01 | |
CY2024Q1 | SSSS |
Investment Company Unrealized Investment Income Loss From Operations Per Share
InvestmentCompanyUnrealizedInvestmentIncomeLossFromOperationsPerShare
|
-0.73 | |
CY2023Q1 | SSSS |
Investment Company Unrealized Investment Income Loss From Operations Per Share
InvestmentCompanyUnrealizedInvestmentIncomeLossFromOperationsPerShare
|
0.30 | |
CY2024Q1 | SSSS |
Investment Company Share Based Compensation Arrangement By Share Based Payment
InvestmentCompanyShareBasedCompensationArrangementByShareBasedPayment
|
0.06 | |
CY2023Q1 | SSSS |
Investment Company Share Based Compensation Arrangement By Share Based Payment
InvestmentCompanyShareBasedCompensationArrangementByShareBasedPayment
|
0.04 | |
CY2024Q1 | us-gaap |
Net Asset Value Per Share
NetAssetValuePerShare
|
7.17 | |
CY2023Q1 | us-gaap |
Net Asset Value Per Share
NetAssetValuePerShare
|
7.59 | |
CY2024Q1 | SSSS |
Market Value Value Per Share
MarketValueValuePerShare
|
4.55 | |
CY2023Q1 | SSSS |
Market Value Value Per Share
MarketValueValuePerShare
|
3.62 | |
CY2024Q1 | SSSS |
Investment Company Total Return Basedon Market Value
InvestmentCompanyTotalReturnBasedonMarketValue
|
0.1548 | pure |
CY2023Q1 | SSSS |
Investment Company Total Return Basedon Market Value
InvestmentCompanyTotalReturnBasedonMarketValue
|
-0.0474 | pure |
CY2024Q1 | us-gaap |
Investment Company Total Return
InvestmentCompanyTotalReturn
|
-0.1026 | pure |
CY2023Q1 | us-gaap |
Investment Company Total Return
InvestmentCompanyTotalReturn
|
0.0271 | pure |
CY2024Q1 | us-gaap |
Shares Outstanding
SharesOutstanding
|
25353284 | shares |
CY2023Q1 | us-gaap |
Shares Outstanding
SharesOutstanding
|
28338580 | shares |
CY2024Q1 | us-gaap |
Assets Net
AssetsNet
|
181721135 | usd |
CY2023Q1 | us-gaap |
Assets Net
AssetsNet
|
215043069 | usd |
CY2024Q1 | SSSS |
Average Net Asset
AverageNetAsset
|
202519594 | usd |
CY2023Q1 | SSSS |
Average Net Asset
AverageNetAsset
|
209347362 | usd |
CY2024Q1 | us-gaap |
Investment Company Expense Ratio After Incentive Allocation
InvestmentCompanyExpenseRatioAfterIncentiveAllocation
|
0.0944 | pure |
CY2023Q1 | us-gaap |
Investment Company Expense Ratio After Incentive Allocation
InvestmentCompanyExpenseRatioAfterIncentiveAllocation
|
0.1070 | pure |
CY2024Q1 | us-gaap |
Investment Company Investment Income Loss Ratio After Incentive Allocation
InvestmentCompanyInvestmentIncomeLossRatioAfterIncentiveAllocation
|
-0.0640 | pure |
CY2023Q1 | us-gaap |
Investment Company Investment Income Loss Ratio After Incentive Allocation
InvestmentCompanyInvestmentIncomeLossRatioAfterIncentiveAllocation
|
-0.0818 | pure |
CY2024Q1 | SSSS |
Investment Company Turnover Ratio After Incentive Allocation
InvestmentCompanyTurnoverRatioAfterIncentiveAllocation
|
0.0018 | pure |
CY2023Q1 | SSSS |
Investment Company Turnover Ratio After Incentive Allocation
InvestmentCompanyTurnoverRatioAfterIncentiveAllocation
|
0.0124 | pure |
CY2024Q1 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
|
0.04 | pure |
CY2024Q1 | us-gaap |
Income Tax Examination Description
IncomeTaxExaminationDescription
|
(1) 98% of its ordinary income (taking into account certain deferrals and elections) for each calendar year, (2) 98.2% of its capital gain net income (adjusted for certain ordinary losses) for the 1-year period ending October 31 of each such calendar year and (3) any ordinary income and net capital gains for preceding years, but not distributed during such years and on which the Company paid no U.S. federal income tax. | |
CY2024Q1 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
|
0.04 | pure |
CY2024Q1 | us-gaap |
Deferred Finance Costs Gross
DeferredFinanceCostsGross
|
1165526 | usd |
CY2023Q4 | us-gaap |
Deferred Finance Costs Gross
DeferredFinanceCostsGross
|
1254793 | usd |
CY2024Q1 | ecd |
Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
|
false | |
CY2024Q1 | ecd |
Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
|
false | |
CY2024Q1 | ecd |
Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
|
false | |
CY2024Q1 | ecd |
Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
|
false |